Dr Arjun Singh

About

Arjun, PharmD

Research Areas & Specialization: Clinical Pharmacology, Drug Utilization, Pharmacovigilance, Pharmacoepidemiology, Public Health, VigiFlow, WHO-ART, ICD-10, ICSR processing, MedDRA, ICH Guidelines review and Causality assessment, PSUR & Drug Regulatory Affairs, Clinical Research & Medical Writing.

Bio:
I am a Pharm.D post graduate in clinical pharmacy & a registered Pharmacist involved in PSUR evaluation & drug alert vigilance. I have comprehensive knowledge of working on Oracle® Argus Safety, ArisG & currently processing spontaneous and clinical trial, vaccine ICSRs, case narrative writing, medical coding (MedDRA), WHO-DD, ART, ICD-10 coding, quality review, query generation, causality assessment, SAE reconciliation and signal detectionin in Vigiflow (UMC) at Pharmacovigilance Program of India under WHO Programme for International Drug Monitoring.
I have clinical exposure from various reputed organizations such as Jaypee Hospital, Fortis Escorts Heart Institute & PGIMER- Chandigarh. I also posses training in Computer Aided Drug Design & Development from Central Drug Research Institute Lucknow.
I aspire to grow as a competent professional in Pharmacovigilance & Regulatory affair industry.

Employment

• Indian Pharmacopoeia Commission Pharmacovigilance Associate
  2020 - Present
• Post Graduate Institute of Medical Education and Research Patient Safety Pharmacovigilance Associate
  2020 - 2021
• Uttrakhand Technical University Lecturer/ Assitant Professor
  2019 - 2020
• Teerthanker Mahaveer Medical College & Research Centre Paid Intern
  2018 - 2019
• Fortis Escorts Heart Institute and Research Centre Intern
  2018 - 2018

Education

• Teerthanker Mahaveer University Doctor of Pharmacy (Pharm.D)
  2013 - 2019

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• Potential Drug-drug Interactions and Adverse Drug Reactions Associated with Hydroxychloroquine
  Indian Journal of Pharmacy Practice 2021 DOI: DOI: 10.5530/ijopp.14.1.10
  +Save
• An Overview on surveillance of Biomedical Devices under Materiovigilance Program of India
  Drug Bulletin 2020
  +Save
• HYDROXYCHLOROQUINE DRUG SAFETY REVIEW FOR THE PROPHYLAXIS OF SARS COV 2 PANDEMIC
  INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH 2020 DOI: 10.13040/IJPSR.0975-8232.11(8).3535-43
  +Save
• E-PRESCRIPTION (CPOE) IN INDIAN HOSPITALS: A STRATEGY TO PREVENT PRESCRIPTION ERRORS
  Drug Bulletin 2020
  +Save
• A STUDY ON ISOLATION AND ANTHELMINITIC ACTIVITY OF MYRISTICA FRAGRANS SEEDS
  International Journal of Innovative Pharmaceutical Sciences and Research 2020 DOI: DOI: 10.21276/IJIPSR.2020.08.06.894
  +Save
• Evaluation of Self-Medication Practice among Pharmacy Students in Roorkee (Northern India)
  Saudi Journal of Medical and Pharmaceutical Sciences 2020 DOI: 10.36348/sjmps.2020.v06i03.004
  +Save
• Current Scenario of Antibiotic Resistant on Indian Community: A Case Study
  Saudi Journal of Medical and Pharmaceutical Sciences 2020 DOI: 10.36348/sjmps.2020.v06i02.002
  +Save
• A Review on Signal in Pharmacovigilance
  Asian Journal of Pharmaceutical Research and Development (AJPRD) 2019 DOI: doi.org/10.22270/ajprd.v7i6.591
  +Save
• Morbidity & mortality associated with medication errors in a tertiary care hospital
  1st National Biomedical Research Competition (NBRCom – 2018) 2018
  +Save
• Bedaquiline: An advancement in the treatment of MDR TB
  International conference on “Global Trends in Pharmaceutical & Clinical Practices” 2015
  +Save